Pramodini Medicare IPO

Pramodini Medicare IPO closed on 14 Aug 2026. Allotment 17 Aug 2026, listing 19 Aug 2026. Price band ₹110–₹118, lot 1200 shares, GMP +₹0 (0%). Track allotment on Allotly.

About Pramodini Medicare

Pramodini Medicare Limited is an Indian diagnostic service provider offering a comprehensive range of technology-enabled services, including radiology, clinical laboratory testing, and nuclear medicine. The company serves public and private hospitals, government Public Sector Undertakings (PSUs), and medical colleges across tier I, II, and III cities. Its core offerings are divided into three segments: Radiology (MRI, CT scans, ultrasound), Clinical Laboratory (pathology, microbiology, immunology), and Nuclear Medicine (PET-CT and nuclear therapy). Additionally, it operates a 24×7 teleradiology service from its registered office in Vijayawada. Pramodini Medicare generates revenue by providing routine and specialized tests for prediction, early detection, and disease monitoring. The business uniquely operates across four key models: Public-Private Partnerships (PPP) with government…

Strengths

• The business model spans PPP, private hospitals, PSUs, and standalone centres.
• The diagnostic network grew from 1 centre in FY15 to 16 centres today.
• Offers specialized services across radiology, clinical laboratory, and nuclear medicine.
• Revenue grew significantly from ₹3,522.95 lakhs in FY24 to ₹6,228.75 lakhs in FY26.
• Leverages public health infrastructure through extensive government MOUs.

Risks

• High dependence on government PPP MOUs subject to non-renewal or delayed payments.
• Focus on capital-intensive radiology exposes the firm to equipment and regulatory risks.
• Over 60% revenue concentration in Andhra Pradesh creates geographic risk.
• Loss of top institutional clients could severely impair revenue and profitability.
• Past statutory filing delays and non-compliances expose the firm to regulatory penalties.

See all IPOs · Apply for your family on Allotly